Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Precipio Debt to Equity Ratio 2010-2024 | PRPO

Current and historical debt to equity ratio values for Precipio (PRPO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Precipio debt/equity for the three months ending June 30, 2024 was 0.02.
  
Precipio Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $0.01B $0.01B 0.43
2024-03-31 $0.00B $0.01B 0.30
2023-12-31 $0.00B $0.01B 0.25
2023-09-30 $0.01B $0.01B 0.47
2023-06-30 $0.01B $0.01B 0.38
2023-03-31 $0.01B $0.01B 0.37
2022-12-31 $0.01B $0.02B 0.31
2022-09-30 $0.01B $0.02B 0.29
2022-06-30 $0.01B $0.02B 0.26
2022-03-31 $0.01B $0.02B 0.26
2021-12-31 $0.01B $0.03B 0.24
2021-09-30 $0.01B $0.03B 0.22
2021-06-30 $0.01B $0.03B 0.23
2021-03-31 $0.01B $0.02B 0.40
2020-12-31 $0.01B $0.01B 0.46
2020-09-30 $0.01B $0.01B 0.50
2020-06-30 $0.01B $0.01B 0.51
2020-03-31 $0.01B $0.01B 0.68
2019-12-31 $0.01B $0.01B 0.48
2019-09-30 $0.01B $0.02B 0.47
2019-06-30 $0.01B $0.01B 0.56
2019-03-31 $0.01B $0.01B 1.20
2018-12-31 $0.02B $0.01B 2.53
2018-09-30 $0.02B $0.01B 1.69
2018-06-30 $0.01B $0.01B 1.12
2018-03-31 $0.01B $0.01B 0.95
2017-12-31 $0.01B $0.01B 1.09
2017-09-30 $0.02B $0.02B 0.71
2017-06-30 $0.02B $0.02B 0.87
2017-03-31 $0.02B $-0.02B -1.06
2016-12-31 $0.01B $-0.01B -1.13
2016-09-30 $0.02B $-0.02B -1.12
2016-06-30 $0.02B $-0.02B -1.19
2016-03-31 $0.02B $-0.02B -1.23
2015-12-31 $0.02B $-0.01B -1.38
2015-09-30 $0.02B $0.01B 2.64
2015-06-30 $0.02B $0.01B 1.88
2015-03-31 $0.02B $0.01B 2.43
2014-12-31 $0.02B $0.01B 3.58
2014-09-30 $0.02B $0.01B 2.02
2014-06-30 $0.02B $0.01B 2.00
2014-03-31 $0.02B $0.01B 1.15
2013-12-31 $0.02B $0.01B 1.65
2013-09-30 $0.02B $0.02B 1.16
2013-06-30 $0.02B $0.02B 0.87
2013-03-31 $0.02B $0.02B 0.72
2012-12-31 $0.02B $0.02B 0.91
2012-09-30 $0.02B $0.02B 0.90
2012-06-30 $0.02B $0.03B 0.76
2012-03-31 $0.02B $0.03B 0.82
2011-12-31 $0.02B $0.01B 2.04
2011-09-30 $0.03B $-0.00B -20.92
2011-06-30 $0.03B $0.00B 275.58
2011-03-31 $0.03B $0.01B 4.62
2010-12-31 $0.02B $0.01B 2.77
2010-09-30 $0.01B $0.01B 0.50
2010-06-30 $0.00B $0.01B 0.45
2010-03-31 $0.01B $0.01B 0.45
2009-12-31 $0.00B $0.01B 0.37
2009-09-30 $0.00B $0.01B 0.34
2009-06-30 $0.00B $0.01B 0.35
2009-03-31 $0.01B $0.01B 0.37
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00